BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 33477865)

  • 1. Improving Global Healthcare and Reducing Costs Using Second-Generation Artificial Intelligence-Based Digital Pills: A Market Disruptor.
    Ilan Y
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33477865
    [No Abstract]   [Full Text] [Related]  

  • 2. Digital Medical Cannabis as Market Differentiator: Second-Generation Artificial Intelligence Systems to Improve Response.
    Ilan Y
    Front Med (Lausanne); 2021; 8():788777. PubMed ID: 35141242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital Analgesic Comprising a Second-Generation Digital Health System: Increasing Effectiveness by Optimizing the Dosing and Minimizing Side Effects.
    Azmanov H; Bayatra A; Ilan Y
    J Pain Res; 2022; 15():1051-1060. PubMed ID: 35444460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Gap Between AI and Bedside: Participatory Workshop on the Barriers to the Integration, Translation, and Adoption of Digital Health Care and AI Startup Technology Into Clinical Practice.
    Olaye IM; Seixas AA
    J Med Internet Res; 2023 May; 25():e32962. PubMed ID: 37129947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital transformation in healthcare - architectures of present and future information technologies.
    Gopal G; Suter-Crazzolara C; Toldo L; Eberhardt W
    Clin Chem Lab Med; 2019 Feb; 57(3):328-335. PubMed ID: 30530878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shaping the future of chronic disease management: Insights into patient needs for AI-based homecare systems.
    Wang B; Asan O; Zhang Y
    Int J Med Inform; 2024 Jan; 181():105301. PubMed ID: 38029700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare costs in renal transplant recipients using branded versus generic ciclosporin.
    Helderman JH; Kang N; Legorreta AP; Chen JY
    Appl Health Econ Health Policy; 2010; 8(1):61-8. PubMed ID: 20038194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-Generation Digital Health Platforms: Placing the Patient at the Center and Focusing on Clinical Outcomes.
    Ilan Y
    Front Digit Health; 2020; 2():569178. PubMed ID: 34713042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital health: a new dimension in rheumatology patient care.
    Kataria S; Ravindran V
    Rheumatol Int; 2018 Nov; 38(11):1949-1957. PubMed ID: 29713795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges to implementing artificial intelligence in healthcare: a qualitative interview study with healthcare leaders in Sweden.
    Petersson L; Larsson I; Nygren JM; Nilsen P; Neher M; Reed JE; Tyskbo D; Svedberg P
    BMC Health Serv Res; 2022 Jul; 22(1):850. PubMed ID: 35778736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoption of Digital Technologies in Health Care During the COVID-19 Pandemic: Systematic Review of Early Scientific Literature.
    Golinelli D; Boetto E; Carullo G; Nuzzolese AG; Landini MP; Fantini MP
    J Med Internet Res; 2020 Nov; 22(11):e22280. PubMed ID: 33079693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial intelligence in healthcare: opportunities and risk for future.
    Sunarti S; Fadzlul Rahman F; Naufal M; Risky M; Febriyanto K; Masnina R
    Gac Sanit; 2021; 35 Suppl 1():S67-S70. PubMed ID: 33832631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engaging Through Awareness: Purpose-Driven Framework Development to Evaluate and Develop Future Business Strategies With Exponential Technologies Toward Healthcare Democratization.
    Barbazzeni B; Haider S; Friebe M
    Front Public Health; 2022; 10():851380. PubMed ID: 35692334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Missing Pieces of Artificial Intelligence in Medicine.
    Gilvary C; Madhukar N; Elkhader J; Elemento O
    Trends Pharmacol Sci; 2019 Aug; 40(8):555-564. PubMed ID: 31277839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming Low Adherence to Chronic Medications by Improving their Effectiveness Using a Personalized Second-generation Digital System.
    Bayatra A; Nasserat R; Ilan Y
    Curr Pharm Biotechnol; 2024 Jan; ():. PubMed ID: 38288794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring healthcare professionals' understanding and experiences of artificial intelligence technology use in the delivery of healthcare: An integrative review.
    Shinners L; Aggar C; Grace S; Smith S
    Health Informatics J; 2020 Jun; 26(2):1225-1236. PubMed ID: 31566454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence framework for simulating clinical decision-making: a Markov decision process approach.
    Bennett CC; Hauser K
    Artif Intell Med; 2013 Jan; 57(1):9-19. PubMed ID: 23287490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic consequences of generic substitution for antiepileptic drugs in a public payer setting: the case of lamotrigine.
    Duh MS; Andermann F; Paradis PE; Weiner J; Manjunath R; Crémieux PY
    Dis Manag; 2007 Aug; 10(4):216-25. PubMed ID: 17718660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using chronobiology-based second-generation artificial intelligence digital system for overcoming antimicrobial drug resistance in chronic infections.
    Kolben Y; Azmanov H; Gelman R; Dror D; Ilan Y
    Ann Med; 2023 Dec; 55(1):311-318. PubMed ID: 36594558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing Healthcare Through Telehealth Ecosystems: Impacts and Prospects.
    Manta O; Vasileiou N; Giannakopoulou O; Bromis K; Kouris I; Haritou M; Matsopoulos GK; Koutsouris DD
    Stud Health Technol Inform; 2023 Oct; 309():302-303. PubMed ID: 37869865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.